Effect of Applying Cooling Gel Pad on the pain of sternal incision associated with deep breathing and coughing.

Effect of Applying Cooling Gel Pad Compared with not using it on reducing the pain of sternal incision associated with deep breathing and coughing in cardiac surgery patient

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201207249422N2

Enrollment

Registered

2012-08-19

Start date

2012-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Chronic ischaemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: application of cooling gel pack before deep breathing and coughing sessions. Intervention 2: Control group: deep breathing and coughing sessions without application

Intervention group: application of cooling gel pack before deep breathing and coughing sessions.

Control group: deep breathing and coughing sessions without application of cooling gel pack

Eligibility

Sex/Gender

All

Age

21 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: more than 21 years age; able to speak and understand Persian; The minimum literacy of Reading and writing; Willing to give written informed consent; male or female patients scheduled to undergo Coronary artery bypass graft surgery with or without a valve replacement using a median sternotomy. Exclusion criteria: Mechanically ventilated patients; diseases that affect pain measurement (Delirium; Dementia or Major depression; Severe visual, hearing and verbal impairment; diabetic patient) contradictions to cryotherapy use such as ( Reynaud’s disease; cryoglobulinemia; sickle cell anemia; cold allergic conditions and in areas with impaired sensation); bilateral mammary harvest; postoperative complications such as (infection; bleeding; uncontrolled Atrial fibrillation or wound dehiscence).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: numeric rating scale (NRS).	—

Secondary

Measure	Time frame
Anxiety. Timepoint: At the beginning application of cooling gel pack and before deep breathing and coughing. Method of measurement: State –Trait Anxiety Inventory.;Quality of pain. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Modified short form MacGill pain Questionnaire.;Blood pressure and heart rate. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Cardiac monitoring machine.;Spo2. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Pulse Oxy-meter.	—

Measure

Time frame

Anxiety. Timepoint: At the beginning application of cooling gel pack and before deep breathing and coughing. Method of measurement: State –Trait Anxiety Inventory.;Quality of pain. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Modified short form MacGill pain Questionnaire.;Blood pressure and heart rate. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Cardiac monitoring machine.;Spo2. Timepoint: Immediately before the application of cooling gel pack and after termination of DB & C sessions in intervention group and Immediately before and after DB & C sessions in control group. Method of measurement: Pulse Oxy-meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Aram Feizi

Urmia University of Medical Sciences

aramfeizi@yahoo.com+98 44 1293 7300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026